A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
ImmunityBio, Inc.
AstraZeneca
NuCana plc
Eli Lilly and Company
GlaxoSmithKline
Dartmouth-Hitchcock Medical Center
Case Comprehensive Cancer Center